PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced ...

CAMBRIDGE, Mass., and PARIS--(BUSINESS WIRE)-- EOS imaging (www.eos-imaging.com) announced today that it has received FDA clearance of its sterEOS 3D orthopedic imaging workstation for use in lower ...

PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. EOS Imaging recently announced a new online service ...

CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)-- EOS imaging (www.eos-imaging.com) announced today that it is retiring the corporate name ‘biospace med’ and will now officially be known as ‘EOS imaging’, ...

Low-Dose 2D/3D Orthopedic Imaging System Adopted by Leading U.S. Hospital CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)-- EOS imaging (NYSE Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic ...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how ...

Please provide your email address to receive an email when new articles are posted on . EOS Imaging announced it received FDA 510(k) clearance to market its kneeEOS software in the United States.

Ongoing Impacts of COVID-19 Pandemic Constitute “Material Adverse Effect” Company Intends to Explore Other Strategic Collaborations with EOS Terminates Debt Commitment of up to $160 Million to Finance ...

SOUTH BEND, IN (WSBT) — Memorial Hospital is using new advanced technology when it comes to X-rays. It is the first hospital in northern Indiana to offer the EOS Imaging System. In this "Eye on Health ...

Alphatec Holdings shares plummeted after the company lowered its full-year revenue outlook. Shares of the medical technology company dropped 32% to $6.97. The shares plunged to a new 52-week low of $6 ...